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  54 
ABSTRACT 55 
Objectives 56 
Surgery for acute Type A aortic dissection carries a high risk of operative mortality. We 57 
examined the surgeon volume-outcome relation with respect to in-hospital mortality for 58 
patients presenting with this pathology in the United Kingdom. 59 
Method: 60 
Between April 2007 and March 2013, 1550 acute Type A aortic dissection procedures were 61 
identified from the National Institute for Cardiovascular Outcomes Research database. 249 62 
responsible consultant cardiac surgeons from the UK recorded one or more of these 63 
procedures in their surgical activity over this time period. We describe the patient population 64 
and mortality rates, focusing on the relationship between surgeon volume and in-hospital 65 
mortality. 66 
Results: 67 
The mean annual volume of procedures per surgeon during the 6-year period ranged from 1 68 
to 6.6. The overall in-hospital mortality rate was 18.3% (283/1550). A mortality improvement 69 
at the 95% level was observed with a risk adjusted mean annual volume >4.5. Surgeons with 70 
a mean annual volume over the study period ≥4 had significantly higher in-hospital mortality 71 
rates in comparison to surgeons with a mean annual volume <4 (19.3% vs. 12.6%; P = 72 
0.015). 73 
Conclusion: 74 
Acute Type A aortic dissection patients who are operated on by lower volume surgeons 75 
experience higher levels of in-hospital mortality. Directing these patients to higher volume 76 
surgeons may be a strategy to reduce in-hospital mortality. 77 
Keywords: aorta, dissection, aneurysm, surgeon volume-outcome, AAD  78 
INTRODUCTION 79 
Acute Type A aortic dissection (ATAD) is a lethal condition and a cardiac 80 
surgical emergency.  The incidence of aortic dissection is 30-43 per million 81 
population per year and this is incrementally increasing1,2,3. Forty percent of patients 82 
with dissection are aged 60 to 74 but 27% are aged 17 to 59 years, thus all ages are 83 
affected4. 84 
In medically treated patients, mortality rates are 1-2% per hour after the initial 85 
event, with death due to coronary or other organ malperfusion, cardiac tamponade, 86 
acute heart failure due to aortic regurgitation or aortic rupture. Emergency surgery can 87 
convert a 90% mortality rate at 30-days to a 75-90% long-term survival rate4. 88 
Mortality rates may vary, the International Registry for Acute Dissection (IRAD)5 and 89 
the UK Society for Cardiothoracic Surgery (SCTS) ‘Blue Book’6 have published 90 
operative mortality rates of 25.1% and 22.8% respectively. In contrast, the German 91 
registry GERAADA published their series with lower rates of 17%7. This variation in 92 
reported mortality might be due to the volume-outcome relationship that has been at 93 
the center of debate and discussion. The Mount Sinai group utilizing the Nationwide 94 
Inpatient Sample of North America reported that lower-volume surgeons and centers 95 
have approximately double the risk-adjusted mortality of patients undergoing repair 96 
by the highest volume care providers8. 97 
This study aims to report the national UK surgeon outcomes in the operated 98 
ATAD patient population and explore the relationship in this population between 99 
surgeon volume and adjusted in-hospital mortality. 100 
  101 
METHODS 102 
NICOR database 103 
Prospectively collected data were extracted from the National Institute for 104 
Cardiovascular Outcomes Research (NICOR) National Adult Cardiac Surgery Audit 105 
(NACSA) registry (version 4.1.2) on 20th November 2014 for all adult cardiac surgery 106 
procedures performed in the UK. As described elsewhere, reproducible cleaning 107 
algorithms were applied to the database9. Briefly, duplicate records and non-adult 108 
cardiac surgery entries [including transcatheter aortic valve implantations (TAVIs)] 109 
were removed, transcriptional discrepancies harmonized and clinical and temporal 110 
conflicts and extreme values corrected or removed. Data summaries are returned 111 
regularly to each unit for local validation as part of the NACSA in the UK10. 112 
For this study, records were included that corresponded to the following 113 
criteria: procedure on one or more of the root, ascending or arch aortic segments with 114 
a recorded pathology of “Acute Dissection” that were performed in England and 115 
Wales between 1st April 2007 and 31st March 2013. Records missing responsible 116 
consultant cardiac surgeon data (recorded in the form of General Medical Council 117 
registration number) were excluded. 118 
Baseline and operative variables 119 
For each procedure, data are recorded on patient characteristics, comorbidities, 120 
surgical team, intraoperative factors and postoperative outcomes. For this study, we 121 
extracted data on patient age at the time of procedure (years), gender, body mass 122 
index [BMI, defined as weight (kg) / height2 (m2)], Canadian Cardiovascular Society 123 
(CCS) angina class, dyspnoea (dichotomized as New York Heart Association 124 
(NYHA) grade < III and NYHA grade ≥ III), recent myocardial infarction (defined as 125 
within 90 days of surgery), history of major cardiac surgery, diabetes (diet or insulin 126 
controlled), smoking status, history of hypertension, serum creatinine >200 μmol/l, 127 
history of renal dysfunction, history of pulmonary disease, history of neurological 128 
dysfunction, extracardiac arteriopathy, preoperative heart rhythm, left ventricular 129 
ejection fraction (classified as <30, 30–50 and >50%), IV inotropes prior to 130 
anaesthesia, preoperative ventilation, preoperative cardiogenic shock, operative 131 
urgency, concomitant CABG and valve procedures, cardiopulmonary bypass time, 132 
aortic cross-clamp time, and circulatory arrest time. 133 
Administrative data were also extracted including: patient admission, 134 
procedure and discharge dates, responsible consultant cardiac surgeon and 135 
anonymized hospital identifier. Further details of variable definitions are available at: 136 
http://www.ucl.ac.uk/nicor/audits/adultcardiac/datasets. 137 
Outcomes 138 
The primary outcome for this study was in-hospital mortality, defined as death 139 
due to any cause during admission to the base hospital for cardiac surgery. The 140 
secondary outcome was mid-term mortality followed up to 5 years. Follow-up data up 141 
until the point of discharge was collected by the NACSA clinical registry system and 142 
post-discharge survival data was collected by linking the records via patient NHS 143 
numbers to the Office for National Statistics (ONS) death registry, which records all 144 
deaths in England and Wales. The final date of follow-up was 30th July 2013. Data on 145 
cause of death was unavailable. An attempt to back-fill missing in-hospital mortality 146 
data was made by record linkage to the ONS registry prior to applying the extraction 147 
criteria. 148 
 149 
Case volumes 150 
For analytical purposes, case volumes are presented both continuously and 151 
categorically. In the continuous analysis, the mean annual case volume (MAV) was 152 
calculated. This was achieved by taking the total number of procedures for each 153 
surgeon and dividing this by the number of years in which they contributed data to the 154 
registry. In the categorical analysis, the case volume was stratified into two groups 155 
(surgeon MAV of ATAD procedures <4 and ≥4 over the study period). The cut point 156 
was selected as being clinically meaningful after the introductory analysis showed it 157 
to be the approximate inflection point for improved mortality. 158 
Statistical analysis 159 
Categorical and dichotomous variables are summarized as absolute number 160 
and percentage. Non-normally distributed continuous data are summarized as median 161 
and inter-quartile range (IQR). The prevalence of missing data in the registry for 162 
baseline and operative measurements, as well as in-hospital mortality, are reported. 163 
Due to the relatively low number of missing data items for the majority of the 164 
variables, categorical variables with missing data were imputed with the baseline 165 
category and continuous variables were imputed with the mean value before 166 
calculations were performed.  167 
Where categorical comparisons are made between groups the chi-squared test 168 
was used, for similar comparisons between continuous variables the Wilcoxon rank-169 
sum test was used.  170 
To quantify the relationship between MAV and in-hospital mortality we 171 
performed three separate multivariable regression analyses. Firstly, an initial 172 
balancing score was fitted for each patient using a mixed-effects linear regression 173 
model. The dependent continuous variable used was a log transformation of the 174 
surgeon MAV, with random intercepts for each hospital, and the following patient 175 
variables were entered as independent variables: age, gender, body mass index, 176 
smoking, renal failure, hypertension, pulmonary disease, neurological disease, 177 
neurological dysfunction, peripheral vascular disease, recent myocardial infarction, 178 
unstable angina, arrhythmia, New York Heart Association class, previous cardiac 179 
surgery, diabetes, ejection fraction, cardiogenic shock, pre-operative ventilation, 180 
operative urgency, cardiopulmonary bypass time, circulatory arrest time, surgery on 181 
the aortic arch and concomitant procedures. The volume-outcome relationship was 182 
then assessed by plotting estimated restricted cubic spline regression functions with 183 
three knots between the surgeon MAV and in-hospital mortality; these were then 184 
adjusted for patient case-mix by entering the balancing score into the regression 185 
model. The spline estimates were based on a standard, fixed effects logistic regression 186 
model. The balancing score therefore acts in a similar way to a propensity score11,12, 187 
but is generalized beyond a dichotomous treatment assignment.  188 
Secondly, in order to examine the contribution of hospital volume to outcome, 189 
a logistic regression model for in-hospital mortality was fitted including random 190 
intercepts for each hospital, with surgeon and hospital MAV entered into the model as 191 
continuous variables, along with the independent demographical and procedural 192 
variables listed above, interactional terms between hospital and surgeon MAV were 193 
also explored. 194 
Thirdly, a similar approach was taken to assessing the contribution of MAV to 195 
mid-term mortality. Cox proportional hazards models were fitted, again with random 196 
intercepts for each hospital and with surgeon and hospital MAV entered into the 197 
model as continuous variables, along with the independent demographical and 198 
procedural variables listed above.  In order to demonstrate any non-proportional 199 
effects of early mortality two models were fitted, one with a start time of the 200 
procedure date and the second with a start time of 90-days post-procedure. 201 
To evaluate the categorical difference in volume, Kaplan-Meier charts were 202 
used to plot the actuarial 5-year survival, incorporating a landmark cutoff of 90 days 203 
where the groupwise mortality rates were rebased to zero. The log-rank test was used 204 
to assess the equivalence of death rates between groups in both phases of the analysis.  205 
Statistical analyses were performed with SAS version 9.3 (SAS Institute, 206 
Cary, NC). In all cases a P value <0.05 was considered statistically significant.   207 
 208 
RESULTS 209 
Characteristics of the study population 210 
1632 patients were identified from the NACSA database as having had 211 
surgery for ATAD during the time period. Patients who had surgery on the 212 
descending and/or thoracoabdominal segments of the aorta (n=63; 3.9%), and 19 213 
(1.2%) records that lacked responsible clinician data were excluded from the analysis. 214 
The 1550 that remained were included in the study analysis dataset, however 162 215 
(10.5%) records lacked follow-up mortality data and are excluded from that element 216 
of the analysis. 217 
The 1550 patients were admitted to 41 different hospitals throughout England 218 
and Wales and were under the care of 249 different consultant cardiac surgeons. The 219 
mean surgeon MAV was 2.6 (SD = 1.2; median (IQR) = 2.3 (1.6, 3.3), with 199 of 220 
249 surgeons (79.9%) performing fewer than 10 procedures overall. A total of 41 221 
surgeons performed a single ATAD procedure. The highest number of procedures 222 
performed by a single surgeon during the study period was 33. The mean hospital 223 
MAV was 9.6 (SD = 4.6; median (IQR) = 8.7 (6.0, 13.2). The highest number of 224 
procedures performed by a single hospital during the study period was 107. 225 
Pre-operative and operative differences between the two categorical groups 226 
are shown in Tables 1 and 2. Surgeons in the lower MAV group were more likely to 227 
operate on patients who had a recent MI, whilst being less likely to operate on patients 228 
with a history of pulmonary disease or patients who required surgery on the aortic 229 
arch. Surgeons in the lower MAV group also reported significantly longer circulatory 230 
arrest times. 231 
In-hospital mortality and case volume 232 
The overall in-hospital mortality rate for all ATAD patients was 18.3% (283 233 
patients). Figure 1 plots the observed in-hospital mortality against the adjusted 234 
surgeon MAV. Somewhat counter-intuitively, the curve begins below the national 235 
mean rate at the lowest volumes then rises and peaks between 2 and 3 procedures per 236 
year, before decreasing in an approximate linear trend in higher volume surgeons. 237 
Significant in-hospital mortality improvements can be observed beyond a surgeon 238 
MAV of 4 to 4.5. 239 
The unadjusted in-hospital mortality rate decreased from 19.3% in the group 240 
of surgeons who had a MAV <4 during the study period to 12.6% in the group who 241 
had a MAV ≥4; P = 0.015 (Table 2). Figure 2a illustrates the groupwise trends in 5-242 
year follow up mortality rates, including a landmark rebasing at 90 days. The early 243 
difference in mortality rates is significant at the 0.05 level (log-rank test P value = 244 
0.028), however this difference is not sustained in the second era, from 90 days to 5 245 
years (P = 0.97). (Figure 2b is a detail from Figure 2a which charts the 90 day 246 
mortality only, included for clarity).  247 
The logistic regression model shown in Table 3 demonstrates a similar in-248 
hospital mortality advantage for surgeons who perform a greater number of 249 
operations, after adjustment for casemix and hospital volume, increasing surgeon 250 
MAV (assessed as a continuous variable) was associated with a significant reduction 251 
to in-hospital mortality (adjusted OR=0.853 (95% CI 0.733 to 0.992) P = 0.039). 252 
Other associated variables were: increasing age, previous cardiac surgery, peripheral 253 
vascular disease, left ventricular ejection fraction <30%, cardiogenic shock, salvage 254 
priority, concomitant CABG procedure, and increasing cardiopulmonary bypass time. 255 
Hospital MAV was not associated with a difference in in-hospital mortality (adjusted 256 
OR=1.005 (95% CI 0.956 to 1.057) P = 0.84). 257 
Figure 3 includes four charts which show the interaction between surgeon and 258 
hospital MAV with regards to in-hospital mortality. The predicted probabilities of in-259 
hospital mortality over the range of surgeon MAV are shown for the 20th, 40th, 60th 260 
and 80th percentiles of hospital MAV (which are, respectively, 5.8, 7.0, 10.2 and 14.3 261 
cases per year). Visual inspection of these allows us to infer that there are no 262 
substantial differences in the relationship between surgeon MAV and in-hospital 263 
mortality as hospital MAV increases. The associated interaction test P value = 0.88. 264 
 265 
Follow-up mortality and case volume 266 
The results of the two Cox proportional hazard models are shown in Table 4. 267 
In the ‘Start time = procedure date’ model, higher surgeon MAV (assessed as a 268 
continuous variable) was again associated with a significant reduction in death 269 
(adjusted HR=0.882 (95% CI 0.801 to 0.972) P = 0.011). Other variables that were 270 
associated with a greater hazard of death were: increasing age, left ventricular ejection 271 
fraction <30%, cardiogenic shock, salvage priority, surgery on the aortic arch, 272 
concomitant CABG procedure and increasing cardiopulmonary bypass time. Hospital 273 
MAV was not significantly associated with a difference in death (adjusted HR=1.029 274 
(95% CI 1.000 to 1.059) P = 0.050). 275 
In the ‘Start time = 90 days post-procedure’ model, higher surgeon MAV was 276 
not associated with a significant reduction in death (adjusted HR=0.920 (95% CI 277 
0.779 to 1.088) P = 0.33). Other variables that were associated with a greater hazard 278 
of death were: increasing age and left ventricular ejection fraction <30%. Hospital 279 
MAV was not significantly associated with a difference in death (adjusted HR=1.020 280 
(95% CI 0.972 to 1.072) P = 0.42), suggesting that the significant effect observed in 281 
the ‘Start time = procedure date’ model is both non-proportional and also greatly 282 
reliant on the large early mortality burden. 283 
 284 
DISCUSSION 285 
It has been shown that out of every 1,000 emergency department patients 286 
presenting with acute back, chest, or abdominal pain, three patients with ATAD are 287 
diagnosed13. This is a fatal condition with a dire prognosis unless the patient receives 288 
immediate surgical intervention. The IRAD has published outcomes from multiple 289 
centres worldwide with an average in-hospital mortality of 25.1% in 200514. European 290 
registries in the United Kingdom and Germany have published operative mortalities 291 
of 23.1% and 17% respectively15. A recent publication from Mount Sinai Medical 292 
Centre, using the Nationwide Inpatient Sample database of 5,184 patients between 293 
2003 and 2008, showed average operative mortality of 21.6%8Error! Bookmark not defined.. 294 
However, in the advent of this decade there are multiple centres worldwide that are 295 
publishing in-hospital mortality rates for ATAD in the single digits16171819. 296 
Throughout the United States the model of aortic supercentres with high 297 
referral rates have existed for some time. It has been suggested that outcomes in 298 
thoracic aortic surgery could be improved nationwide in the United States if the acute 299 
care and emergency surgical treatment of most patients with ATAD were regionalized 300 
and restricted to institutions with high-volume multidisciplinary thoracic aortic 301 
surgery programs20. 302 
Andersen et al. from the Duke group published their results pertaining to the 303 
impact model of a multi-disciplinary team approach to ATAD17. They reported 304 
operative mortality before multi-disciplinary implementation was 33.9% and was 305 
statistically equivalent to the expected operative mortality rate of 26.0%. Operative 306 
mortality after multi-disciplinary implementation fell to 2.8% and was statistically 307 
better than the expected operative mortality rate of 18.2% using the International 308 
Registry of Acute Aortic Dissection pre-operative prediction model.  309 
In the UK, centralization of expertise and service provision for type A aortic 310 
dissection does not exist. Operating on ATAD does not generally follow a selective 311 
referral protocol which in effect leads to a national mix and match between high and 312 
low volume surgeons. Compounding this is the lack of best practice evidence on 313 
structured referral from emergency room to operating room. This is due to multiple 314 
factors which unfortunately have not been quantified in the UK. Those factors are in 315 
essence related to lack of swift recognition of ATAD. There is also lack of substantial 316 
evidence on the actual time to referral once ATAD is actually identified. The 317 
aforementioned mandate a policy that will serve better patients’ outcome and results 318 
across the UK.  319 
Evidence of improved outcomes related to operative volume or surgeon 320 
expertise is often difficult to establish due to the infrequent nature of ATAD and 321 
consequent lack of statistical power that could potentially provide meaningful 322 
analysis21.  323 
The ideal definition of volume is inherently inconsistent; this makes diving 324 
into a discussion involving ‘volume’ highlight caveats that are not potentially attained 325 
or addressed between cardiac surgical units at large. The strong rationale of the 326 
volume-outcome relationship as reflected in literature springs from the catalyst for 327 
subspecialisation and centralization of aortic services. It is to provide centres with a 328 
large and reaching catchment areas the reciprocal improvement and effect on the 329 
subspecialized unit. It allows more robust referral to influx and therefore maintain an 330 
adequate voluminous exposure. Essentially, in the UK, thoracic aortic aneurysm 331 
service is in much need of such an approach and a national policy and mandate that 332 
would support such programs across the UK should be warranted.  This should 333 
provide a sustained increase in volume to concentrated expertise that would allow the 334 
possibility to address dire surgical diseases and avert associated complications. It will 335 
then reciprocate this arrangement by ultimately reducing mortality and perhaps 336 
improving survival and aftercare post-surgery22.  Beside this, the advent of 337 
technological superiority in diagnosis and surgical planning of aortic surgery and the 338 
understanding of the natural history is resulting in personalized and targeted therapies 339 
and surgical procedures to be done on a wider range of the affected population. This 340 
has allowed for such cost-effective diagnostic tests to be distributed to a smaller 341 
number of regional centres and for them to operate on this patient cohort. Hence, this 342 
has titrated the inexistence of specialist centres and diverted a large number of 343 
patients to be operated at local lower-volume institutions.  344 
The development of standardization and subspecialisation of acute aortic 345 
services requires a comprehensive assessment of the current status in aortic surgery in 346 
the UK. As such, our analysis has demonstrated that there is significant variation of 347 
in-hospital mortality around the country with little relationship between volume and 348 
outcome at a hospital level. These results are contrary to those demonstrated by 349 
international groups including the Mount Sinai group utilizing the Nationwide 350 
Inpatient Sample of North America who reported that lower-volume surgeons and 351 
centres have approximately double the risk-adjusted mortality of patients undergoing 352 
repair by the highest volume care providers23. 353 
Our study does however demonstrate that higher individual surgeon volume 354 
was associated with lower in-hospital mortality. These relationships could be 355 
explained by a number of different factors such as; case mix per individual surgeon, 356 
selection bias and variations in turn down practice, concentration of expertise to a 357 
particular surgeon within a hospital and inadvertent subspecialisation of a surgeon 358 
with interests to aortic interventions.  On the other hand, and as demonstrated in the 359 
context of the analysis; difference between low and high volume surgeons clearly 360 
point out the shorter aortic cross clamp and cardiopulmonary time but increased 361 
circulatory arrest time in the low-volume group which could be related to attempt of 362 
more frequent use or extended repair entailing arch segment replacement. Although 363 
this is not entirely understood, one way of scoping this further would be to look at this 364 
element within the cohort and run a thorough factor analysis 365 
While this study demonstrates good overall mortality rates for ATAD in the 366 
UK, it is likely that further improvements could be achieved through the introduction 367 
of a quality improvement programme for ATAD surgery. It is vital that such a 368 
programme is implemented across the multidisciplinary thoracic aortic surgery team 369 
including anaesthesia, postoperative surgical intensive care and operative perfusion 370 
specialists. Such a programme should also involve standardized referral pathways and 371 
treatment protocols for ATAD repair. Another important contributing factor would be 372 
the development and implementation of a robust referral system and an initiative to 373 
hospital managers and commissioners for centralization of expertise in ATAD repair. 374 
This will reduce the waiting time and taxing of ATAD patients unnecessarily in acute 375 
services while diagnostics are being carried out.  376 
Limitations  377 
The main limitation of this study is its retrospective nature and the variable 378 
nature of data quality between institutions in the UK. There are also several 379 
confounding variables to consider that are not available in the NICOR dataset. The 380 
foremost of these factors is probably case selection: surgeons at tertiary referral 381 
centres are likely to operate on patients significantly longer after the acute event than 382 
local units; consequently their surgical outcomes may benefit from both temporal 383 
patient selection (more stable patients are more likely to survive transfer), and more 384 
aggressive individual patient selection informed by the additional complications (such 385 
as malperfusion syndromes) that manifest hours to days after initial presentation. 386 
Other possible confounding variables include delays between diagnosis and 387 
intervention, referral bias and clustering, and presence, severity, and duration of end-388 
organ ischemia.  389 
 CONCLUSIONS 390 
Concentration of expertise and volume to appropriate surgeons who perform 391 
increasingly more complex aortic cases would be required to change the current 392 
paradigm of ATAD outcomes in the UK. Whenever feasible, ATAD repair should be 393 
performed by a high volume surgeon in order to reduce operative mortality. It is 394 
reasonable to suggest a national standardization and quality improvement framework 395 
for ATAD treatment. 396 
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Table 1: Patient characteristics, stratified by surgeon MAV group 
  
Mean annual volume < 4  
(n=1319) 
Mean annual volume ≥ 4  
(n=231) P value   Missing Data 
Age at procedure (years) 63 (52, 72) 64 (53, 74) 0.10 
 
0 (0) 
Female gender 425 (32.2) 69 (29.9) 0.48 
 
0 (0) 
Body mass index (kg/m2) 26.4 (23.9, 29.7) 26.4 (24.2, 29.0) 0.54 
 
48 (3.5) 
Angina class IV 199 (15.1) 39 (16.9) 0.48 
 
17 (1.1) 
NYHA class ≥ III 354 (26.8) 68 (29.4) 0.41 
 
23 (1.5) 
Previous Q-wave MI 130 (9.9) 18 (7.8) 0.32 
 
14 (0.9) 
Recent MI (within 90 days) 83 (6.3) 4 (1.7) 0.006 
 
10 (0.7) 
Previous PCI 44 (3.3) 6 (2.6) 0.56 
 
39 (2.5) 
Previous cardiac surgery 75 (5.7) 20 (8.7) 0.08 
 
127 (8.2) 
Diabetes (diet or insulin controlled) 62 (4.7) 6 (2.6) 0.15 
 
13 (0.8) 
Current smoker 243 (18.4) 34 (14.7) 0.18 
 
64 (4.1) 
History of hypertension 905 (68.6) 167 (72.3) 0.26 
 
27 (1.7) 
Creatinine > 200 μmol/L 67 (5.1) 16 (6.9) 0.25 
 
115 (7.4) 
History of renal dysfunction 32 (2.4) 8 (3.5) 0.36 
 
71 (4.6) 
History of pulmonary disease 134 (10.2) 34 (14.7) 0.04 
 
9 (0.6) 
History of neurological disease 130 (9.9) 29 (12.6) 0.21 
 
23 (1.5) 
History of neurological dysfunction 93 (7.1) 20 (8.7) 0.39 
 
15 (1.0) 
Peripheral vascular disease 259 (19.6) 47 (20.4) 0.80 
 
16 (1.0) 
Non-sinus heart rhythm 120 (9.1) 18 (7.8) 0.52 
 
99 (6.4) 
Triple vessel disease 29 (2.2) 5 (2.2) 0.97 
 
338 (21.8) 
Left ventricular ejection fraction 30% - 50% 248 (18.8) 39 (16.9) 0.49 
 
31 (2.0) 
Left ventricular ejection fraction <30% 50 (3.8) 7 (3.0) 0.57 
 
31 (2.0) 
Intravenous nitrates or any heparin  200 (15.2) 29 (12.6) 0.30 
 
6 (0.4) 
Intravenous inotropes prior to anaesthesia 100 (7.6) 10 (4.3) 0.08 
 
10 (0.7) 
Pre-operative ventilation 77 (5.8) 12 (5.2) 0.70 
 
15 (1.0) 
Pre-operative cardiogenic shock 228 (17.3) 29 (12.6) 0.07   14 (0.9) 
Continuous variables shown as median (25th percentile, 75th percentile); categorical variables shown as frequency (%) 
   NYHA = New York Heart Association, MI = Myocardial Infarction, PCI = Percutaneous Coronary Intervention 
      
  
Table 2: Operative characteristics and in-hospital mortality, stratified by surgeon MAV group 
 
  
Mean annual volume < 4  
(n=1319) 
Mean annual volume ≥ 4  
(n=231) P value   Missing Data 
Surgeon mean annual volume 2.0 (1.5, 2.7) 4.7 (4.3, 5.0) <0.001 
 
0 (0) 
Hospital mean annual volume 8.7 (6.0, 13.2) 10.2 (8.7, 17.8) <0.001 
 
0 (0) 
      Elective procedure 21 (1.6) 3 (1.3) >0.99 
 
0 (0) 
Urgent procedure 169 (12.8) 34 (14.7) 0.43 
 
0 (0) 
Emergency procedure 1037 (78.6) 181 (78.4) 0.93 
 
0 (0) 
Salvage procedure 92 (7.0) 13 (5.6) 0.45 
 
0 (0) 
Root segment 438 (33.2) 82 (35.5) 0.50 
 
0 (0) 
Ascending segment 1146 (86.9) 203 (87.9) 0.68 
 
0 (0) 
Arch segment 152 (11.5) 46 (19.9) <0.001 
 
0 (0) 
Concomitant CABG procedure 171 (13.0) 30 (13.0) 0.99 
 
30 (1.9) 
Concomitant Valve procedure 521 (39.5) 99 (42.9) 0.34 
 
29 (1.9) 
Concomitant ‘Other’ cardiac procedure 395 (30.0) 76 (32.9) 0.37 
 
34 (2.2) 
Cardiopulmonary bypass time (mins) 196 (152, 259) 197 (154, 254) 0.86 
 
44 (2.8) 
Aortic cross clamp time (mins) 105 (74, 143) 109 (68, 147) 0.81 
 
56 (3.6) 
Circulatory arrest time (mins) 29 (20, 39) 20 (15, 31) <0.001 
 
402 (25.9) 
      In-hospital mortality 254 (19.3) 29 (12.6) 0.015   0 (0) 
Continuous variables shown as median (25th percentile, 75th percentile); categorical variables shown as frequency (%) 
   CABG = Coronary Artery Bypass Grafting 
      
  
Table 3: Logistic regression analysis for in-hospital mortality 
 
Variable Odds ratio 95% confidence interval P value 
Surgeon mean annual volume 0.853 0.733 - 0.992 0.039 
Hospital mean annual volume 1.005 0.956 - 1.057 0.84 
Age at procedure (years) 1.028 1.015 - 1.041 <0.001 
Previous cardiac surgery 1.840 1.052 - 3.218 0.033 
Peripheral vascular disease 1.505 1.051 - 2.156 0.026 
Left ventricular ejection fraction <30% 2.896 1.374 - 6.104 0.005 
Pre-operative cardiogenic shock 1.722 1.137 - 2.607 0.010 
Salvage procedure 5.474 2.790 - 10.741 <0.001 
Concomitant CABG procedure 2.135 1.412 - 3.229 <0.001 
Cardiopulmonary bypass time (mins) 1.003 1.002 - 1.005 <0.001 
 
 
Table 4: Cox proportional hazards analysis for survival from procedure and from 90-days post-procedure 
 
Variable 
Start time = procedure date   Start time = 90 days post-procedure 
Hazard ratio 95% confidence interval P value   Hazard ratio 
95% confidence 
interval P value 
Surgeon mean annual volume 0.882 0.801 - 0.972 0.011  0.920 0.779 - 1.088 0.33 
Hospital mean annual volume 1.029 1.000 - 1.059 0.050  1.020 0.972 - 1.072 0.42 
Age at procedure (years) 1.028 1.019 - 1.037 <0.001  1.043 1.023 - 1.063 <0.001 
Left ventricular ejection fraction <30% 2.495 1.586 - 3.926 <0.001  5.799 2.169 - 15.505 <0.001 
Pre-operative cardiogenic shock 1.426 1.068 - 1.903 0.016  0.880 0.459 - 1.687 0.70 
Salvage procedure 3.250 2.139 - 4.965 <0.001  2.138 0.791 - 5.778 0.13 
Arch segment 1.414 1.047 - 1.909 0.024  1.200 0.653 - 2.207 0.56 
Concomitant CABG procedure 1.629 1.235 - 2.150 <0.001  1.215 0.636 - 2.323 0.56 
Cardiopulmonary bypass time (mins) 1.003 1.002 - 1.004 <0.001   1.001 0.998 - 1.003 0.53 
Figure 1: Trend in mean annual volume (MAV) of ATAD activity and observed mortality.  Each black dot corresponds to the mean mortality 
(vertical axis) for ATAD procedures performed by consultant surgeons with a specific MAV (horizontal axis). The size of the black dots is 
proportional to the total number of ATAD procedures performed by surgeons with the given MAV. Please note that although volume was modelled 
continuously, to improve legibility the number of surgeon procedures is grouped for every 0.25 of a year, therefore each dot can be comprised of 
multiple consultant surgeons. The blue line is a fitted smoothing curve to illustrate the trend, adjusted for pre-operative risk factors, and the grey-
shaded area denotes approximate 95% confidence intervals. The red horizontal line represents the overall mean observed in-hospital mortality 
(18.3%) for the study cohort. 
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Figure 2a: Kaplan-Meier chart showing the cumulative probability of all-cause mortality for ATAD patients in the surgeon MAV groups. Landmark 
rebasing occurs at 90 days. Colored bands show approximate 95% confidence intervals. 
 
Figure 2b: Kaplan-Meier chart showing the cumulative probability of all-cause mortality for ATAD patients in the surgeon MAV groups. Colored 
bands show approximate 95% confidence intervals. (0-90 day detail from Figure 2a). 
 
  
Figure 3: Panel chart showing the interaction between hospital and surgeon volume. The blue lines in each chart represent predicted probabilities of 
in-hospital mortality over the range of surgeon MAV for the 20th, 40th, 60th and 80th percentiles of hospital MAV, and the grey-shaded areas denote 
approximate 95% confidence intervals. Overall P value for interaction = 0.88 
 
Supplemental Figure 1: Kaplan-Meier chart showing the cumulative probability of all-cause mortality for ATAD patients in the surgeon MAV 
groups. Colored bands show approximate 95% confidence intervals. 
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Variable Odds ratio 95% confidence interval P value 
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Hospital mean annual volume 1.005 0.956 - 1.057 0.84 
Age at procedure (years) 1.028 1.015 - 1.041 <0.001 
Previous cardiac surgery 1.840 1.052 - 3.218 0.033 
Peripheral vascular disease 1.505 1.051 - 2.156 0.026 
Left ventricular ejection fraction <30% 2.896 1.374 - 6.104 0.005 
Pre-operative cardiogenic shock 1.722 1.137 - 2.607 0.010 
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Table 3 - Logistic regression analysis for in-hospital mortality
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Female gender 425 (32.2) 69 (29.9) 0.48 
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Body mass index (kg/m2) 26.4 (23.9, 29.7) 26.4 (24.2, 29.0) 0.54 
 
48 (3.5) 
Angina class IV 199 (15.1) 39 (16.9) 0.48 
 
17 (1.1) 
NYHA class ≥ III 354 (26.8) 68 (29.4) 0.41 
 
23 (1.5) 
Previous Q-wave MI 130 (9.9) 18 (7.8) 0.32 
 
14 (0.9) 
Recent MI (within 90 days) 83 (6.3) 4 (1.7) 0.006 
 
10 (0.7) 
Previous PCI 44 (3.3) 6 (2.6) 0.56 
 
39 (2.5) 
Previous cardiac surgery 75 (5.7) 20 (8.7) 0.08 
 
127 (8.2) 
Diabetes (diet or insulin controlled) 62 (4.7) 6 (2.6) 0.15 
 
13 (0.8) 
Current smoker 243 (18.4) 34 (14.7) 0.18 
 
64 (4.1) 
History of hypertension 905 (68.6) 167 (72.3) 0.26 
 
27 (1.7) 
Creatinine > 200 μmol/L 67 (5.1) 16 (6.9) 0.25 
 
115 (7.4) 
History of renal dysfunction 32 (2.4) 8 (3.5) 0.36 
 
71 (4.6) 
History of pulmonary disease 134 (10.2) 34 (14.7) 0.04 
 
9 (0.6) 
History of neurological disease 130 (9.9) 29 (12.6) 0.21 
 
23 (1.5) 
History of neurological dysfunction 93 (7.1) 20 (8.7) 0.39 
 
15 (1.0) 
Peripheral vascular disease 259 (19.6) 47 (20.4) 0.80 
 
16 (1.0) 
Non-sinus heart rhythm 120 (9.1) 18 (7.8) 0.52 
 
99 (6.4) 
Triple vessel disease 29 (2.2) 5 (2.2) 0.97 
 
338 (21.8) 
Left ventricular ejection fraction 30% - 50% 248 (18.8) 39 (16.9) 0.49 
 
31 (2.0) 
Left ventricular ejection fraction <30% 50 (3.8) 7 (3.0) 0.57 
 
31 (2.0) 
Intravenous nitrates or any heparin  200 (15.2) 29 (12.6) 0.30 
 
6 (0.4) 
Intravenous inotropes prior to anaesthesia 100 (7.6) 10 (4.3) 0.08 
 
10 (0.7) 
Pre-operative ventilation 77 (5.8) 12 (5.2) 0.70 
 
15 (1.0) 
Pre-operative cardiogenic shock 228 (17.3) 29 (12.6) 0.07   14 (0.9) 
Continuous variables shown as median (25th percentile, 75th percentile); categorical variables shown as frequency (%) 
   NYHA = New York Heart Association, MI = Myocardial Infarction, PCI = Percutaneous Coronary Intervention 
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Mean annual volume < 4  
(n=1319) 
Mean annual volume ≥ 4  
(n=231) P value   Missing Data 
Surgeon mean annual volume 2.0 (1.5, 2.7) 4.7 (4.3, 5.0) <0.001 
 
0 (0) 
Hospital mean annual volume 8.7 (6.0, 13.2) 10.2 (8.7, 17.8) <0.001 
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0 (0) 
Emergency procedure 1037 (78.6) 181 (78.4) 0.93 
 
0 (0) 
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Root segment 438 (33.2) 82 (35.5) 0.50 
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Ascending segment 1146 (86.9) 203 (87.9) 0.68 
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Arch segment 152 (11.5) 46 (19.9) <0.001 
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Concomitant CABG procedure 171 (13.0) 30 (13.0) 0.99 
 
30 (1.9) 
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Table 4: Cox proportional hazards analysis for survival from procedure and from 90-days post-procedure 
 
Variable 
Start time = procedure date   Start time = 90 days post-procedure 
Hazard ratio 95% confidence interval P value   Hazard ratio 
95% confidence 
interval P value 
Surgeon mean annual volume 0.882 0.801 - 0.972 0.011  0.920 0.779 - 1.088 0.33 
Hospital mean annual volume 1.029 1.000 - 1.059 0.050  1.020 0.972 - 1.072 0.42 
Age at procedure (years) 1.028 1.019 - 1.037 <0.001  1.043 1.023 - 1.063 <0.001 
Left ventricular ejection fraction <30% 2.495 1.586 - 3.926 <0.001  5.799 2.169 - 15.505 <0.001 
Pre-operative cardiogenic shock 1.426 1.068 - 1.903 0.016  0.880 0.459 - 1.687 0.70 
Salvage procedure 3.250 2.139 - 4.965 <0.001  2.138 0.791 - 5.778 0.13 
Arch segment 1.414 1.047 - 1.909 0.024  1.200 0.653 - 2.207 0.56 
Concomitant CABG procedure 1.629 1.235 - 2.150 <0.001  1.215 0.636 - 2.323 0.56 
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Table 4 - Cox proportional hazards analysis for survival from procedure and from 90-days
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ABSTRACT 55 
Objectives 56 
Surgery for acute Type A aortic dissection carries a high risk of operative mortality. We 57 
examined the surgeon volume-outcome relation with respect to in-hospital mortality for 58 
patients presenting with this pathology in the United Kingdom. 59 
Method: 60 
Between April 2007 and March 2013, 1550 acute Type A aortic dissection procedures were 61 
identified from the National Institute for Cardiovascular Outcomes Research database. 249 62 
responsible consultant cardiac surgeons from the UK recorded one or more of these 63 
procedures in their surgical activity over this time period. We describe the patient population 64 
and mortality rates, focusing on the relationship between surgeon volume and in-hospital 65 
mortality. 66 
Results: 67 
The mean annual volume of procedures per surgeon during the 6-year period ranged from 1 68 
to 6.6. The overall in-hospital mortality rate was 18.3% (283/1550). A mortality improvement 69 
at the 95% level was observed with a risk adjusted mean annual volume >4.5. Surgeons with 70 
a mean annual volume over the study period ≥4 had significantly higher in-hospital mortality 71 
rates in comparison to surgeons with a mean annual volume <4 (19.3% vs. 12.6%; P = 72 
0.015). 73 
Conclusion: 74 
Acute Type A aortic dissection patients who are operated on by lower volume surgeons 75 
experience higher levels of in-hospital mortality. Directing these patients to higher volume 76 
surgeons may be a strategy to reduce in-hospital mortality. 77 
Keywords: aorta, dissection, aneurysm, surgeon volume-outcome, AAD  78 
INTRODUCTION 79 
Acute Type A aortic dissection (ATAD) is a lethal condition and a cardiac 80 
surgical emergency.  The incidence of aortic dissection is 30-43 per million 81 
population per year and this is incrementally increasing1,2,3. Forty percent of patients 82 
with dissection are aged 60 to 74 but 27% are aged 17 to 59 years, thus all ages are 83 
affected4. 84 
In medically treated patients, mortality rates are 1-2% per hour after the initial 85 
event, with death due to coronary or other organ malperfusion, cardiac tamponade, 86 
acute heart failure due to aortic regurgitation or aortic rupture. Emergency surgery can 87 
convert a 90% mortality rate at 30-days to a 75-90% long-term survival rate4. 88 
Mortality rates may vary, the International Registry for Acute Dissection (IRAD)5 and 89 
the UK Society for Cardiothoracic Surgery (SCTS) ‘Blue Book’6 have published 90 
operative mortality rates of 25.1% and 22.8% respectively. In contrast, the German 91 
registry GERAADA published their series with lower rates of 17%7. This variation in 92 
reported mortality might be due to the volume-outcome relationship that has been at 93 
the center of debate and discussion. The Mount Sinai group utilizing the Nationwide 94 
Inpatient Sample of North America reported that lower-volume surgeons and centers 95 
have approximately double the risk-adjusted mortality of patients undergoing repair 96 
by the highest volume care providers8. 97 
This study aims to report the national UK surgeon outcomes in the operated 98 
ATAD patient population and explore the relationship in this population between 99 
surgeon volume and adjusted in-hospital mortality. 100 
  101 
METHODS 102 
NICOR database 103 
Prospectively collected data were extracted from the National Institute for 104 
Cardiovascular Outcomes Research (NICOR) National Adult Cardiac Surgery Audit 105 
(NACSA) registry (version 4.1.2) on 20th November 2014 for all adult cardiac surgery 106 
procedures performed in the UK. As described elsewhere, reproducible cleaning 107 
algorithms were applied to the database9. Briefly, duplicate records and non-adult 108 
cardiac surgery entries [including transcatheter aortic valve implantations (TAVIs)] 109 
were removed, transcriptional discrepancies harmonized and clinical and temporal 110 
conflicts and extreme values corrected or removed. Data summaries are returned 111 
regularly to each unit for local validation as part of the NACSA in the UK10. 112 
For this study, records were included that corresponded to the following 113 
criteria: procedure on one or more of the root, ascending or arch aortic segments with 114 
a recorded pathology of “Acute Dissection” that were performed in England and 115 
Wales between 1st April 2007 and 31st March 2013. Records missing responsible 116 
consultant cardiac surgeon data (recorded in the form of General Medical Council 117 
registration number) were excluded. 118 
Baseline and operative variables 119 
For each procedure, data are recorded on patient characteristics, comorbidities, 120 
surgical team, intraoperative factors and postoperative outcomes. For this study, we 121 
extracted data on patient age at the time of procedure (years), gender, body mass 122 
index [BMI, defined as weight (kg) / height2 (m2)], Canadian Cardiovascular Society 123 
(CCS) angina class, dyspnoea (dichotomized as New York Heart Association 124 
(NYHA) grade < III and NYHA grade ≥ III), recent myocardial infarction (defined as 125 
within 90 days of surgery), history of major cardiac surgery, diabetes (diet or insulin 126 
controlled), smoking status, history of hypertension, serum creatinine >200 μmol/l, 127 
history of renal dysfunction, history of pulmonary disease, history of neurological 128 
dysfunction, extracardiac arteriopathy, preoperative heart rhythm, left ventricular 129 
ejection fraction (classified as <30, 30–50 and >50%), IV inotropes prior to 130 
anaesthesia, preoperative ventilation, preoperative cardiogenic shock, operative 131 
urgency, concomitant CABG and valve procedures, cardiopulmonary bypass time, 132 
aortic cross-clamp time, and circulatory arrest time. 133 
Administrative data were also extracted including: patient admission, 134 
procedure and discharge dates, responsible consultant cardiac surgeon and 135 
anonymized hospital identifier. Further details of variable definitions are available at: 136 
http://www.ucl.ac.uk/nicor/audits/adultcardiac/datasets. 137 
Outcomes 138 
The primary outcome for this study was in-hospital mortality, defined as death 139 
due to any cause during admission to the base hospital for cardiac surgery. The 140 
secondary outcome was mid-term mortality followed up to 5 years. Follow-up data up 141 
until the point of discharge was collected by the NACSA clinical registry system and 142 
post-discharge survival data was collected by linking the records via patient NHS 143 
numbers to the Office for National Statistics (ONS) death registry, which records all 144 
deaths in England and Wales. The final date of follow-up was 30th July 2013. Data on 145 
cause of death was unavailable. An attempt to back-fill missing in-hospital mortality 146 
data was made by record linkage to the ONS registry prior to applying the extraction 147 
criteria. 148 
 149 
Case volumes 150 
For analytical purposes, case volumes are presented both continuously and 151 
categorically. In the continuous analysis, the mean annual case volume (MAV) was 152 
calculated. This was achieved by taking the total number of procedures for each 153 
surgeon and dividing this by the number of years in which they contributed data to the 154 
registry. In the categorical analysis, the case volume was stratified into two groups 155 
(surgeon MAV of ATAD procedures <4 and ≥4 over the study period). The cut point 156 
was selected as being clinically meaningful after the introductory analysis showed it 157 
to be the approximate inflection point for improved mortality. 158 
Statistical analysis 159 
Categorical and dichotomous variables are summarized as absolute number 160 
and percentage. Non-normally distributed continuous data are summarized as median 161 
and inter-quartile range (IQR). The prevalence of missing data in the registry for 162 
baseline and operative measurements, as well as in-hospital mortality, are reported. 163 
Due to the relatively low number of missing data items for the majority of the 164 
variables, categorical variables with missing data were imputed with the baseline 165 
category and continuous variables were imputed with the mean value before 166 
calculations were performed.  167 
Where categorical comparisons are made between groups the chi-squared test 168 
was used, for similar comparisons between continuous variables the Wilcoxon rank-169 
sum test was used.  170 
To quantify the relationship between MAV and in-hospital mortality we 171 
performed three separate multivariable regression analyses. Firstly, an initial 172 
balancing score was fitted for each patient using a mixed-effects linear regression 173 
model. The dependent continuous variable used was a log transformation of the 174 
surgeon MAV, with random intercepts for each hospital, and the following patient 175 
variables were entered as independent variables: age, gender, body mass index, 176 
smoking, renal failure, hypertension, pulmonary disease, neurological disease, 177 
neurological dysfunction, peripheral vascular disease, recent myocardial infarction, 178 
unstable angina, arrhythmia, New York Heart Association class, previous cardiac 179 
surgery, diabetes, ejection fraction, cardiogenic shock, pre-operative ventilation, 180 
operative urgency, cardiopulmonary bypass time, circulatory arrest time, surgery on 181 
the aortic arch and concomitant procedures. The volume-outcome relationship was 182 
then assessed by plotting estimated restricted cubic spline regression functions with 183 
three knots between the surgeon MAV and in-hospital mortality; these were then 184 
adjusted for patient case-mix by entering the balancing score into the regression 185 
model. The spline estimates were based on a standard, fixed effects logistic regression 186 
model. The balancing score therefore acts in a similar way to a propensity score11,12, 187 
but is generalized beyond a dichotomous treatment assignment.  188 
Secondly, in order to examine the contribution of hospital volume to outcome, 189 
a logistic regression model for in-hospital mortality was fitted including random 190 
intercepts for each hospital, with surgeon and hospital MAV entered into the model as 191 
continuous variables, along with the independent demographical and procedural 192 
variables listed above, interactional terms between hospital and surgeon MAV were 193 
also explored. 194 
Thirdly, a similar approach was taken to assessing the contribution of MAV to 195 
mid-term mortality. Cox proportional hazards models were fitted, again with random 196 
intercepts for each hospital and with surgeon and hospital MAV entered into the 197 
model as continuous variables, along with the independent demographical and 198 
procedural variables listed above.  In order to demonstrate any non-proportional 199 
effects of early mortality two models were fitted, one with a start time of the 200 
procedure date and the second with a start time of 90-days post-procedure. 201 
To evaluate the categorical difference in volume, Kaplan-Meier charts were 202 
used to plot the actuarial 5-year survival, incorporating a landmark cutoff of 90 days 203 
where the groupwise mortality rates were rebased to zero. The log-rank test was used 204 
to assess the equivalence of death rates between groups in both phases of the analysis.  205 
Statistical analyses were performed with SAS version 9.3 (SAS Institute, 206 
Cary, NC). In all cases a P value <0.05 was considered statistically significant.   207 
 208 
RESULTS 209 
Characteristics of the study population 210 
1632 patients were identified from the NACSA database as having had 211 
surgery for ATAD during the time period. Patients who had surgery on the 212 
descending and/or thoracoabdominal segments of the aorta (n=63; 3.9%), and 19 213 
(1.2%) records that lacked responsible clinician data were excluded from the analysis. 214 
The 1550 that remained were included in the study analysis dataset, however 162 215 
(10.5%) records lacked follow-up mortality data and are excluded from that element 216 
of the analysis. 217 
The 1550 patients were admitted to 41 different hospitals throughout England 218 
and Wales and were under the care of 249 different consultant cardiac surgeons. The 219 
mean surgeon MAV was 2.6 (SD = 1.2; median (IQR) = 2.3 (1.6, 3.3), with 199 of 220 
249 surgeons (79.9%) performing fewer than 10 procedures overall. A total of 41 221 
surgeons performed a single ATAD procedure. The highest number of procedures 222 
performed by a single surgeon during the study period was 33. The mean hospital 223 
MAV was 9.6 (SD = 4.6; median (IQR) = 8.7 (6.0, 13.2). The highest number of 224 
procedures performed by a single hospital during the study period was 107. 225 
Pre-operative and operative differences between the two categorical groups 226 
are shown in Tables 1 and 2. Surgeons in the lower MAV group were more likely to 227 
operate on patients who had a recent MI, whilst being less likely to operate on patients 228 
with a history of pulmonary disease or patients who required surgery on the aortic 229 
arch. Surgeons in the lower MAV group also reported significantly longer circulatory 230 
arrest times. 231 
In-hospital mortality and case volume 232 
The overall in-hospital mortality rate for all ATAD patients was 18.3% (283 233 
patients). Figure 1 plots the observed in-hospital mortality against the adjusted 234 
surgeon MAV. Somewhat counter-intuitively, the curve begins below the national 235 
mean rate at the lowest volumes then rises and peaks between 2 and 3 procedures per 236 
year, before decreasing in an approximate linear trend in higher volume surgeons. 237 
Significant in-hospital mortality improvements can be observed beyond a surgeon 238 
MAV of 4 to 4.5. 239 
The unadjusted in-hospital mortality rate decreased from 19.3% in the group 240 
of surgeons who had a MAV <4 during the study period to 12.6% in the group who 241 
had a MAV ≥4; P = 0.015 (Table 2). Figure 2a illustrates the groupwise trends in 5-242 
year follow up mortality rates, including a landmark rebasing at 90 days. The early 243 
difference in mortality rates is significant at the 0.05 level (log-rank test P value = 244 
0.028), however this difference is not sustained in the second era, from 90 days to 5 245 
years (P = 0.97). (Figure 2b is a detail from Figure 2a which charts the 90 day 246 
mortality only, included for clarity).  247 
The logistic regression model shown in Table 3 demonstrates a similar in-248 
hospital mortality advantage for surgeons who perform a greater number of 249 
operations, after adjustment for casemix and hospital volume, increasing surgeon 250 
MAV (assessed as a continuous variable) was associated with a significant reduction 251 
to in-hospital mortality (adjusted OR=0.853 (95% CI 0.733 to 0.992) P = 0.039). 252 
Other associated variables were: increasing age, previous cardiac surgery, peripheral 253 
vascular disease, left ventricular ejection fraction <30%, cardiogenic shock, salvage 254 
priority, concomitant CABG procedure, and increasing cardiopulmonary bypass time. 255 
Hospital MAV was not associated with a difference in in-hospital mortality (adjusted 256 
OR=1.005 (95% CI 0.956 to 1.057) P = 0.84). 257 
Figure 3 includes four charts which show the interaction between surgeon and 258 
hospital MAV with regards to in-hospital mortality. The predicted probabilities of in-259 
hospital mortality over the range of surgeon MAV are shown for the 20th, 40th, 60th 260 
and 80th percentiles of hospital MAV (which are, respectively, 5.8, 7.0, 10.2 and 14.3 261 
cases per year). Visual inspection of these allows us to infer that there are no 262 
substantial differences in the relationship between surgeon MAV and in-hospital 263 
mortality as hospital MAV increases. The associated interaction test P value = 0.88. 264 
 265 
Follow-up mortality and case volume 266 
The results of the two Cox proportional hazard models are shown in Table 4. 267 
In the ‘Start time = procedure date’ model, higher surgeon MAV (assessed as a 268 
continuous variable) was again associated with a significant reduction in death 269 
(adjusted HR=0.882 (95% CI 0.801 to 0.972) P = 0.011). Other variables that were 270 
associated with a greater hazard of death were: increasing age, left ventricular ejection 271 
fraction <30%, cardiogenic shock, salvage priority, surgery on the aortic arch, 272 
concomitant CABG procedure and increasing cardiopulmonary bypass time. Hospital 273 
MAV was not significantly associated with a difference in death (adjusted HR=1.029 274 
(95% CI 1.000 to 1.059) P = 0.050). 275 
In the ‘Start time = 90 days post-procedure’ model, higher surgeon MAV was 276 
not associated with a significant reduction in death (adjusted HR=0.920 (95% CI 277 
0.779 to 1.088) P = 0.33). Other variables that were associated with a greater hazard 278 
of death were: increasing age and left ventricular ejection fraction <30%. Hospital 279 
MAV was not significantly associated with a difference in death (adjusted HR=1.020 280 
(95% CI 0.972 to 1.072) P = 0.42), suggesting that the significant effect observed in 281 
the ‘Start time = procedure date’ model is both non-proportional and also greatly 282 
reliant on the large early mortality burden. 283 
 284 
DISCUSSION 285 
It has been shown that out of every 1,000 emergency department patients 286 
presenting with acute back, chest, or abdominal pain, three patients with ATAD are 287 
diagnosed13. This is a fatal condition with a dire prognosis unless the patient receives 288 
immediate surgical intervention. The IRAD has published outcomes from multiple 289 
centres worldwide with an average in-hospital mortality of 25.1% in 200514. European 290 
registries in the United Kingdom and Germany have published operative mortalities 291 
of 23.1% and 17% respectively15. A recent publication from Mount Sinai Medical 292 
Centre, using the Nationwide Inpatient Sample database of 5,184 patients between 293 
2003 and 2008, showed average operative mortality of 21.6%8Error! Bookmark not defined.. 294 
However, in the advent of this decade there are multiple centres worldwide that are 295 
publishing in-hospital mortality rates for ATAD in the single digits16171819. 296 
Throughout the United States the model of aortic supercentres with high 297 
referral rates have existed for some time. It has been suggested that outcomes in 298 
thoracic aortic surgery could be improved nationwide in the United States if the acute 299 
care and emergency surgical treatment of most patients with ATAD were regionalized 300 
and restricted to institutions with high-volume multidisciplinary thoracic aortic 301 
surgery programs20. 302 
Andersen et al. from the Duke group published their results pertaining to the 303 
impact model of a multi-disciplinary team approach to ATAD17. They reported 304 
operative mortality before multi-disciplinary implementation was 33.9% and was 305 
statistically equivalent to the expected operative mortality rate of 26.0%. Operative 306 
mortality after multi-disciplinary implementation fell to 2.8% and was statistically 307 
better than the expected operative mortality rate of 18.2% using the International 308 
Registry of Acute Aortic Dissection pre-operative prediction model.  309 
In the UK, centralization of expertise and service provision for type A aortic 310 
dissection does not exist. Operating on ATAD does not generally follow a selective 311 
referral protocol which in effect leads to a national mix and match between high and 312 
low volume surgeons. Compounding this is the lack of best practice evidence on 313 
structured referral from emergency room to operating room. This is due to multiple 314 
factors which unfortunately have not been quantified in the UK. Those factors are in 315 
essence related to lack of swift recognition of ATAD. There is also lack of substantial 316 
evidence on the actual time to referral once ATAD is actually identified. The 317 
aforementioned mandate a policy that will serve better patients’ outcome and results 318 
across the UK.  319 
Evidence of improved outcomes related to operative volume or surgeon 320 
expertise is often difficult to establish due to the infrequent nature of ATAD and 321 
consequent lack of statistical power that could potentially provide meaningful 322 
analysis21.  323 
The ideal definition of volume is inherently inconsistent; this makes diving 324 
into a discussion involving ‘volume’ highlight caveats that are not potentially attained 325 
or addressed between cardiac surgical units at large. The strong rationale of the 326 
volume-outcome relationship as reflected in literature springs from the catalyst for 327 
subspecialisation and centralization of aortic services. It is to provide centres with a 328 
large and reaching catchment areas the reciprocal improvement and effect on the 329 
subspecialized unit. It allows more robust referral to influx and therefore maintain an 330 
adequate voluminous exposure. Essentially, in the UK, thoracic aortic aneurysm 331 
service is in much need of such an approach and a national policy and mandate that 332 
would support such programs across the UK should be warranted.  This should 333 
provide a sustained increase in volume to concentrated expertise that would allow the 334 
possibility to address dire surgical diseases and avert associated complications. It will 335 
then reciprocate this arrangement by ultimately reducing mortality and perhaps 336 
improving survival and aftercare post-surgery22.  Beside this, the advent of 337 
technological superiority in diagnosis and surgical planning of aortic surgery and the 338 
understanding of the natural history is resulting in personalized and targeted therapies 339 
and surgical procedures to be done on a wider range of the affected population. This 340 
has allowed for such cost-effective diagnostic tests to be distributed to a smaller 341 
number of regional centres and for them to operate on this patient cohort. Hence, this 342 
has titrated the inexistence of specialist centres and diverted a large number of 343 
patients to be operated at local lower-volume institutions.  344 
The development of standardization and subspecialisation of acute aortic 345 
services requires a comprehensive assessment of the current status in aortic surgery in 346 
the UK. As such, our analysis has demonstrated that there is significant variation of 347 
in-hospital mortality around the country with little relationship between volume and 348 
outcome at a hospital level. These results are contrary to those demonstrated by 349 
international groups including the Mount Sinai group utilizing the Nationwide 350 
Inpatient Sample of North America who reported that lower-volume surgeons and 351 
centres have approximately double the risk-adjusted mortality of patients undergoing 352 
repair by the highest volume care providers23. 353 
Our study does however demonstrate that higher individual surgeon volume 354 
was associated with lower in-hospital mortality. These relationships could be 355 
explained by a number of different factors such as; case mix per individual surgeon, 356 
selection bias and variations in turn down practice, concentration of expertise to a 357 
particular surgeon within a hospital and inadvertent subspecialisation of a surgeon 358 
with interests to aortic interventions.  On the other hand, and as demonstrated in the 359 
context of the analysis; difference between low and high volume surgeons clearly 360 
point out the shorter aortic cross clamp and cardiopulmonary time but increased 361 
circulatory arrest time in the low-volume group which could be related to attempt of 362 
more frequent use or extended repair entailing arch segment replacement. Although 363 
this is not entirely understood, one way of scoping this further would be to look at this 364 
element within the cohort and run a thorough factor analysis 365 
While this study demonstrates good overall mortality rates for ATAD in the 366 
UK, it is likely that further improvements could be achieved through the introduction 367 
of a quality improvement programme for ATAD surgery. It is vital that such a 368 
programme is implemented across the multidisciplinary thoracic aortic surgery team 369 
including anaesthesia, postoperative surgical intensive care and operative perfusion 370 
specialists. Such a programme should also involve standardized referral pathways and 371 
treatment protocols for ATAD repair. Another important contributing factor would be 372 
the development and implementation of a robust referral system and an initiative to 373 
hospital managers and commissioners for centralization of expertise in ATAD repair. 374 
This will reduce the waiting time and taxing of ATAD patients unnecessarily in acute 375 
services while diagnostics are being carried out.  376 
Limitations  377 
The main limitation of this study is its retrospective nature and the variable 378 
nature of data quality between institutions in the UK. There are also several 379 
confounding variables to consider that are not available in the NICOR dataset. The 380 
foremost of these factors is probably case selection: surgeons at tertiary referral 381 
centres are likely to operate on patients significantly longer after the acute event than 382 
local units; consequently their surgical outcomes may benefit from both temporal 383 
patient selection (more stable patients are more likely to survive transfer), and more 384 
aggressive individual patient selection informed by the additional complications (such 385 
as malperfusion syndromes) that manifest hours to days after initial presentation. 386 
Other possible confounding variables include delays between diagnosis and 387 
intervention, referral bias and clustering, and presence, severity, and duration of end-388 
organ ischemia.  389 
 CONCLUSIONS 390 
Concentration of expertise and volume to appropriate surgeons who perform 391 
increasingly more complex aortic cases would be required to change the current 392 
paradigm of ATAD outcomes in the UK. Whenever feasible, ATAD repair should be 393 
performed by a high volume surgeon in order to reduce operative mortality. It is 394 
reasonable to suggest a national standardization and quality improvement framework 395 
for ATAD treatment. 396 
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Table 1: Patient characteristics, stratified by surgeon MAV group 
  
Mean annual volume < 4  
(n=1319) 
Mean annual volume ≥ 4  
(n=231) P value   Missing Data 
Age at procedure (years) 63 (52, 72) 64 (53, 74) 0.10 
 
0 (0) 
Female gender 425 (32.2) 69 (29.9) 0.48 
 
0 (0) 
Body mass index (kg/m2) 26.4 (23.9, 29.7) 26.4 (24.2, 29.0) 0.54 
 
48 (3.5) 
Angina class IV 199 (15.1) 39 (16.9) 0.48 
 
17 (1.1) 
NYHA class ≥ III 354 (26.8) 68 (29.4) 0.41 
 
23 (1.5) 
Previous Q-wave MI 130 (9.9) 18 (7.8) 0.32 
 
14 (0.9) 
Recent MI (within 90 days) 83 (6.3) 4 (1.7) 0.006 
 
10 (0.7) 
Previous PCI 44 (3.3) 6 (2.6) 0.56 
 
39 (2.5) 
Previous cardiac surgery 75 (5.7) 20 (8.7) 0.08 
 
127 (8.2) 
Diabetes (diet or insulin controlled) 62 (4.7) 6 (2.6) 0.15 
 
13 (0.8) 
Current smoker 243 (18.4) 34 (14.7) 0.18 
 
64 (4.1) 
History of hypertension 905 (68.6) 167 (72.3) 0.26 
 
27 (1.7) 
Creatinine > 200 μmol/L 67 (5.1) 16 (6.9) 0.25 
 
115 (7.4) 
History of renal dysfunction 32 (2.4) 8 (3.5) 0.36 
 
71 (4.6) 
History of pulmonary disease 134 (10.2) 34 (14.7) 0.04 
 
9 (0.6) 
History of neurological disease 130 (9.9) 29 (12.6) 0.21 
 
23 (1.5) 
History of neurological dysfunction 93 (7.1) 20 (8.7) 0.39 
 
15 (1.0) 
Peripheral vascular disease 259 (19.6) 47 (20.4) 0.80 
 
16 (1.0) 
Non-sinus heart rhythm 120 (9.1) 18 (7.8) 0.52 
 
99 (6.4) 
Triple vessel disease 29 (2.2) 5 (2.2) 0.97 
 
338 (21.8) 
Left ventricular ejection fraction 30% - 50% 248 (18.8) 39 (16.9) 0.49 
 
31 (2.0) 
Left ventricular ejection fraction <30% 50 (3.8) 7 (3.0) 0.57 
 
31 (2.0) 
Intravenous nitrates or any heparin  200 (15.2) 29 (12.6) 0.30 
 
6 (0.4) 
Intravenous inotropes prior to anaesthesia 100 (7.6) 10 (4.3) 0.08 
 
10 (0.7) 
Pre-operative ventilation 77 (5.8) 12 (5.2) 0.70 
 
15 (1.0) 
Pre-operative cardiogenic shock 228 (17.3) 29 (12.6) 0.07   14 (0.9) 
Continuous variables shown as median (25th percentile, 75th percentile); categorical variables shown as frequency (%) 
   NYHA = New York Heart Association, MI = Myocardial Infarction, PCI = Percutaneous Coronary Intervention 
      
  
Table 2: Operative characteristics and in-hospital mortality, stratified by surgeon MAV group 
 
  
Mean annual volume < 4  
(n=1319) 
Mean annual volume ≥ 4  
(n=231) P value   Missing Data 
Surgeon mean annual volume 2.0 (1.5, 2.7) 4.7 (4.3, 5.0) <0.001 
 
0 (0) 
Hospital mean annual volume 8.7 (6.0, 13.2) 10.2 (8.7, 17.8) <0.001 
 
0 (0) 
      Elective procedure 21 (1.6) 3 (1.3) >0.99 
 
0 (0) 
Urgent procedure 169 (12.8) 34 (14.7) 0.43 
 
0 (0) 
Emergency procedure 1037 (78.6) 181 (78.4) 0.93 
 
0 (0) 
Salvage procedure 92 (7.0) 13 (5.6) 0.45 
 
0 (0) 
Root segment 438 (33.2) 82 (35.5) 0.50 
 
0 (0) 
Ascending segment 1146 (86.9) 203 (87.9) 0.68 
 
0 (0) 
Arch segment 152 (11.5) 46 (19.9) <0.001 
 
0 (0) 
Concomitant CABG procedure 171 (13.0) 30 (13.0) 0.99 
 
30 (1.9) 
Concomitant Valve procedure 521 (39.5) 99 (42.9) 0.34 
 
29 (1.9) 
Concomitant ‘Other’ cardiac procedure 395 (30.0) 76 (32.9) 0.37 
 
34 (2.2) 
Cardiopulmonary bypass time (mins) 196 (152, 259) 197 (154, 254) 0.86 
 
44 (2.8) 
Aortic cross clamp time (mins) 105 (74, 143) 109 (68, 147) 0.81 
 
56 (3.6) 
Circulatory arrest time (mins) 29 (20, 39) 20 (15, 31) <0.001 
 
402 (25.9) 
      In-hospital mortality 254 (19.3) 29 (12.6) 0.015   0 (0) 
Continuous variables shown as median (25th percentile, 75th percentile); categorical variables shown as frequency (%) 
   CABG = Coronary Artery Bypass Grafting 
      
  
Table 3: Logistic regression analysis for in-hospital mortality 
 
Variable Odds ratio 95% confidence interval P value 
Surgeon mean annual volume 0.853 0.733 - 0.992 0.039 
Hospital mean annual volume 1.005 0.956 - 1.057 0.84 
Age at procedure (years) 1.028 1.015 - 1.041 <0.001 
Previous cardiac surgery 1.840 1.052 - 3.218 0.033 
Peripheral vascular disease 1.505 1.051 - 2.156 0.026 
Left ventricular ejection fraction <30% 2.896 1.374 - 6.104 0.005 
Pre-operative cardiogenic shock 1.722 1.137 - 2.607 0.010 
Salvage procedure 5.474 2.790 - 10.741 <0.001 
Concomitant CABG procedure 2.135 1.412 - 3.229 <0.001 
Cardiopulmonary bypass time (mins) 1.003 1.002 - 1.005 <0.001 
 
 
Table 4: Cox proportional hazards analysis for survival from procedure and from 90-days post-procedure 
 
Variable 
Start time = procedure date   Start time = 90 days post-procedure 
Hazard ratio 95% confidence interval P value   Hazard ratio 
95% confidence 
interval P value 
Surgeon mean annual volume 0.882 0.801 - 0.972 0.011  0.920 0.779 - 1.088 0.33 
Hospital mean annual volume 1.029 1.000 - 1.059 0.050  1.020 0.972 - 1.072 0.42 
Age at procedure (years) 1.028 1.019 - 1.037 <0.001  1.043 1.023 - 1.063 <0.001 
Left ventricular ejection fraction <30% 2.495 1.586 - 3.926 <0.001  5.799 2.169 - 15.505 <0.001 
Pre-operative cardiogenic shock 1.426 1.068 - 1.903 0.016  0.880 0.459 - 1.687 0.70 
Salvage procedure 3.250 2.139 - 4.965 <0.001  2.138 0.791 - 5.778 0.13 
Arch segment 1.414 1.047 - 1.909 0.024  1.200 0.653 - 2.207 0.56 
Concomitant CABG procedure 1.629 1.235 - 2.150 <0.001  1.215 0.636 - 2.323 0.56 
Cardiopulmonary bypass time (mins) 1.003 1.002 - 1.004 <0.001   1.001 0.998 - 1.003 0.53 
Figure 1: Trend in mean annual volume (MAV) of ATAD activity and observed mortality.  Each black dot corresponds to the mean mortality 
(vertical axis) for ATAD procedures performed by consultant surgeons with a specific MAV (horizontal axis). The size of the black dots is 
proportional to the total number of ATAD procedures performed by surgeons with the given MAV. Please note that although volume was modelled 
continuously, to improve legibility the number of surgeon procedures is grouped for every 0.25 of a year, therefore each dot can be comprised of 
multiple consultant surgeons. The blue line is a fitted smoothing curve to illustrate the trend, adjusted for pre-operative risk factors, and the grey-
shaded area denotes approximate 95% confidence intervals. The red horizontal line represents the overall mean observed in-hospital mortality 
(18.3%) for the study cohort. 
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Figure 2a: Kaplan-Meier chart showing the cumulative probability of all-cause mortality for ATAD patients in the surgeon MAV groups. Landmark 
rebasing occurs at 90 days. Colored bands show approximate 95% confidence intervals. 
 
Figure 2b: Kaplan-Meier chart showing the cumulative probability of all-cause mortality for ATAD patients in the surgeon MAV groups. Colored 
bands show approximate 95% confidence intervals. (0-90 day detail from Figure 2a). 
 
  
Figure 3: Panel chart showing the interaction between hospital and surgeon volume. The blue lines in each chart represent predicted probabilities of 
in-hospital mortality over the range of surgeon MAV for the 20th, 40th, 60th and 80th percentiles of hospital MAV, and the grey-shaded areas denote 
approximate 95% confidence intervals. Overall P value for interaction = 0.88 
 
Supplemental Figure 1: Kaplan-Meier chart showing the cumulative probability of all-cause mortality for ATAD patients in the surgeon MAV 
groups. Colored bands show approximate 95% confidence intervals. 
 
 
